🇺🇸 FDA

Company profile · Sponsor

Viking

Viking Therapeutics

VKTX · NYSE pharma SAN DIEGO, CA, USA
Pipeline
6
Drugs
0
Patents
8

Quick answer

Viking (VKTX) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker VKTX
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, USA
SEC CIK 0001607678

Pipeline (6)

Search pipeline →

  1. VK2735

    Viking

    Weight Loss

    phase 3 small molecule active

    4 trials

  2. Placebo

    Viking

    Weight Loss

    phase 2 small molecule completed

    1 trial

  3. VK2809

    Viking

    Hyperlipidemia

    phase 2 small molecule completed

    1 trial

  4. VK2809

    Viking

    NASH - Nonalcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  5. VK5211

    Viking

    Hip Fractures

    phase 2 small molecule completed

    1 trial

  6. VK0214

    Viking

    Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12421282

    Compositions and methods for the treatment of metabolic and liver disorders

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12318426

    Compositions and methods for the treatment of metabolic and liver disorders

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12102646

    Compositions for the treatment of fibrosis and inflammation

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12083184

    Hydrogel prodrug for treatment

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11951114

    Use of thyroid beta-agonists

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11752217

    Hydrogel prodrug for treatment

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744873

    Compositions and methods for the treatment of metabolic and liver disorders

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11707472

    Compositions for the treatment of fibrosis

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Viking?

Viking (VKTX) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Viking sponsor?

We track 6 ClinicalTrials.gov-linked programs for Viking, including VK2735 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Viking company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.